Ananda Pharma’s ENDOCAN study explores whether pharmaceutical-grade CBD can address unmet needs in endometriosis care
Ananda Pharma launches Phase 2 ENDOCAN trial testing cannabidiol MRX1 for endometriosis pain. Explore what this study could change for women’s health.